טוען...
Transdermal Asenapine in Schizophrenia: A Systematic Review
BACKGROUND: Asenapine is a novel antipsychotic that has demonstrated efficacy in controlling psychosis in schizophrenia and mania in bipolar illness. It must be administered as a sublingual formulation because it is nearly completely metabolized in the first pass through the liver. Recently, a trans...
שמור ב:
| הוצא לאור ב: | Patient Prefer Adherence |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7468370/ https://ncbi.nlm.nih.gov/pubmed/32943849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S235104 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|